Non-interventional Observational Study to Evaluate the Baseline FSH, Ovarian Volume and AFC (Antral Follicle Count) as Prognostic Factors of the Outcome of the In-vitro Fertilization/Intracytosolic Sperm Injection (IVF/ICSI) in Infertile Patients Who Receive r-FSH (GONAL-f) for Controlled Ovarian Hyperstimulation

Trial Profile

Non-interventional Observational Study to Evaluate the Baseline FSH, Ovarian Volume and AFC (Antral Follicle Count) as Prognostic Factors of the Outcome of the In-vitro Fertilization/Intracytosolic Sperm Injection (IVF/ICSI) in Infertile Patients Who Receive r-FSH (GONAL-f) for Controlled Ovarian Hyperstimulation

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2013

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 21 Nov 2012 New source identified and integrated (German Clinical Trials Register).
    • 27 Mar 2012 Actual patient number added 356 according to ClinicalTrials.gov.
    • 27 Mar 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top